Funding available for SMEs producing innovative medical technologies

Competition opens: Monday 26 November 2018
Competition closes: Wednesday 30 January 2019 12:00pm

Innovate UK and the Office for Life Sciences (OLS) will invest up to £1.5 million to SMEs developing innovative medtech. Companies may apply for either of:

  • Planning and preparation for a study. Project costs can be up to £50,000
  • A study to collect clinical performance and cost-effectiveness data. Project costs can be up to £250,000

The funders say:

“This competition aims to provide support for micro, small and medium-sized enterprises (SMEs). We are looking for studies that aim to develop an evidence base for products that address NHS priorities. Our support will allow companies to collect and analyse clinical performance and cost effectiveness data in an NHS setting.”

The full competition details are available here. MAP believes the competition is especially relevant to those companies considering META as a part of their MedTech product’s route to market, but please see the eligibility criteria given below for more advice:

Lead applicant

To lead a project or work alone you must:

  • be an SME based in England, Scotland, Wales or Northern Ireland
  • carry out your project within the NHS
  • have a product that is aligned with the specific priority healthcare areas defined in the ‘Next steps on the NHS 5 year forward view
  • involve products that have been marketed in the UK for less than 5 years
  • be able to outline relevant discussions you have had with the main stakeholders, such as the National Institute for Health and Care Excellence (NICE), National Institute of Health Research (NIHR) and Academic Health Science Networks (AHSNs), to demonstrate the feasibility of your proposal

SMEs can work alone or in collaboration with other businesses or research organisations as unfunded partners or sub-contractors. Only the SME leading the project can claim grant funding.

Tagged with

Published on 29. November 2018 in News, News UK